Joseph Ciaffoni - Jun 1, 2021 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
President and CEO, Director
Signature
/s/ Shirley R. Kuhlmann as Attorney-In-Fact For Joseph Ciaffoni
Stock symbol
COLL
Transactions as of
Jun 1, 2021
Transactions value $
-$483,385
Form type
4
Date filed
6/3/2021, 04:16 PM
Next filing
Jul 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Tax liability -$107K -4.67K -1.68% $22.90 274K Jun 1, 2021 Direct F1
transaction COLL Common Stock Options Exercise $133K +16.2K +5.92% $8.22 290K Jun 1, 2021 Direct
transaction COLL Common Stock Sale -$123K -5.38K -1.85% $22.93 284K Jun 1, 2021 Direct F2, F3
transaction COLL Common Stock Sale -$253K -10.8K -3.81% $23.33 274K Jun 1, 2021 Direct F2, F4
transaction COLL Common Stock Sale -$134K -5.86K -2.14% $22.81 268K Jun 2, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -16.2K -100% $0.00* 0 Jun 1, 2021 Common Stock 16.2K $8.22 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.79 to $22.99, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4).
F4 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.88, inclusive.
F5 All of the 16,205 option shares are exercisable.